Table 3.
Multi-drug Resistant Organisms (MDROs) Detected, by Study Phase
| Infections, Bath Basin Phase (rate/1000 patient days) N=7981 patient days |
Infections, Washcloth Phase (rate/1000 patient days) N=8053 patient days |
IRR (95% CI) | p | |
|---|---|---|---|---|
| Total MDROs | 40 (5.0) | 25 (3.1) | 0.62 (0.36–1.05) | 0.06 |
| Methicillin-resistant Staphylococcus aureus | 12 (1.5) | 12 (1.5) | 0.99 (0.41–2.41) | 0.98 |
| Vancomycin-resistant Enterococcus spp | 5 (0.6) | 2 (0.2) | 0.39 (0.04–2.42) | 0.28 |
| Acinetobacter baumannii | 7 (0.9) | 2 (0.2) | 0.28 (0.03–1.49) | 0.11 |
| Extended-spectrum beta-lactamase producing Klebsiella pneumonia | 3 (0.4) | 2 (0.2) | 0.66 (0.06–5.77) | 0.68 |
| Pseudomonas aeruginosa | 13 (1.6) | 7 (0.9) | 0.53 (0.18–1.44) | 0.18 |
IRR: Incidence Rate Ratio.